| Document and Entity Information | Jun. 08, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jun. 8, 2022 |
| Entity Registrant Name | Reata Pharmaceuticals, Inc. |
| Entity Central Index Key | 0001358762 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-37785 |
| Entity Tax Identification Number | 11-3651945 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 5320 Legacy Drive |
| Entity Address, City or Town | Plano |
| Entity Address, State or Province | TX |
| Entity Address, Postal Zip Code | 75024 |
| City Area Code | 972 |
| Local Phone Number | 865-2219 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of each class | Class A Common Stock, Par Value $0.001 Per Share |
| Trading Symbol | RETA |
| Name of each exchange on which registered | NASDAQ |
